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Validation of a Clinical Scoring System for Outcome Prediction in
Dogs with Acute Kidney Injury Managed by Hemodialysis
G. Segev, C. Langston, K. Takada, P.H. Kass, and L.D. Cowgill
Background: A scoring system for outcome prediction in dogs with acute kidney injury (AKI) recently has been developed
but has not been validated.
Hypothesis: The scoring system previously developed for outcome prediction will accurately predict outcome in a valida-
tion cohort of dogs with AKI managed with hemodialysis.
Animals: One hundred fifteen client-owned dogs with AKI.
Methods: Medical records of dogs with AKI treated by hemodialysis between 2011 and 2015 were reviewed. Dogs were
included only if all variables required to calculate the final predictive score were available, and the 30-day outcome was
known. A predictive score for 3 models was calculated for each dog. Logistic regression was used to evaluate the association
of the final predictive score with each model’s outcome. Receiver operating curve (ROC) analyses were performed to deter-
mine sensitivity and specificity for each model based on previously established cut-off values.
Results: Higher scores for each model were associated with decreased survival probability (P < .001). Based on previously
established cut-off values, 3 models (models A, B, C) were associated with sensitivities/specificities of 73/75%, 71/80%, and
75/86%, respectively, and correctly classified 74–80% of the dogs.
Conclusions and Clinical Relevance: All models were simple to apply and allowed outcome prediction that closely corre-
sponded with actual outcome in an independent cohort. As expected, accuracies were slightly lower compared with those
from the previously reported cohort used initially to develop the models.
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Acute kidney injury (AKI) leading to severe uremiais associated with high morbidity and mortality.1,2
Most dogs with AKI are managed medically, but when
the disease is severe or the kidney dysfunction is pro-
longed, the clinical and pathologic consequences of
AKI may no longer be managed effectively with con-
ventional medical therapy. Hemodialysis is an advanced
extracorporeal renal replacement therapy for uremic
and overhydrated patients, with the capability to
remove uremic toxins, correct fluid and electrolyte
imbalance, restore acid-base balance, and sustain the
life of the patient until the kidney injury resolves.3 As a
consequence, hemodialysis extends life expectancies of
patients with severe uremia and expands the window of
opportunity for recovery and the potential for a favor-
able outcome. Nonetheless, the mortality of patients
with AKI managed with hemodialysis remains as high
as 50%.3
The availability of renal replacement therapies in
veterinary medicine is growing, and it has become the
advanced standard of care for animal patients with
AKI. However, it remains a costly therapy with limited
regional availability and may not be recommended in
the light of the unknown prognosis for a favorable out-
come. Therefore, it would be valuable to have a prog-
nostic tool that could assist with outcome prediction of
animals with AKI when contemplating management
with hemodialysis.
Scoring systems are used to assess objectively the
severity of diseases and aid clinicians and owners when
making decisions regarding the likelihood of survival
before electing a complicated and expensive therapeutic
option. The information required to assess disease
severity and potential for favorable outcome must be
available within the first hours of hospitalization, when
therapeutic decisions must be made. Recently, we devel-
oped a statistically derived scoring system for dogs with
AKI managed with hemodialysis.3 This scoring system
was based on clinically available variables obtained at
admission from 182 dogs with AKI managed by
hemodialysis at 1 tertiary referral center.3 The scoring
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algorithms evaluated clinical signs and clinicopathologic
abnormalities available on the first day of hospitaliza-
tion. From these inputs, a final predictive score was
used to assess the probability of 30-day survival. Vari-
ables associated with survival were evaluated further by
assigning weighting factors to each of the variables
based on the odds ratio (OR) relating survival to devia-
tions of each of the variables from their respective refer-
ence ranges or reference categories. For each dog, all
weighting factors were summed to calculate an individ-
ual final predictive score. Four prototype models were
developed, of which 3 performed well (models A–C). In
model A, the OR for survival for each variable was
rounded to an integer value; in model B, the exact OR
was used; and in model C, the etiology (if known) also
was incorporated into the model. Models A–C correctly
classified outcomes in 81–87% of the dogs, with corre-
sponding sensitivities/specificities of 77/85%, 81/85%,
and 83/90%, respectively.
Because this AKI scoring system was developed and
validated using the same patient population enrolled
from a single referral center, it might not perform as
well if applied to a more diverse patient population.
The aim of this study was to evaluate further and vali-
date the prototype scoring system in an independent
cohort of patients.
Material and Methods
Patients and Data Collection
Medical records of dogs with AKI presented to the teaching
hospitals of the University of California, Davis, CA; the Animal
Medical Center, New York City, NY; and the Koret School of
Veterinary Medicine, Hebrew University, Jerusalem, between 2011
and 2015 and managed with hemodialysis but not used in the ini-
tial development and validation of the prototype AKI scoring sys-
tem were reviewed.
Acute kidney injury was defined using the same criteria used in
the previous study3: (1) acute onset of consistent clinical signs and
history (eg, anuria, oliguria, vomiting, diarrhea, inappetence); (2)
renal azotemia (serum creatinine concentration >3 mg/dL and
urine-specific gravity <1.025); and (3) normal or enlarged kidney
size (relative to the dog’s body weight) as detected by ultrasound
examination. Dogs with historical azotemia or imaging findings
(eg, small irregular kidneys, decreased corticomedullary distinc-
tion) at presentation consistent with chronic kidney disease were
excluded, as were dogs with postrenal azotemia.
Data extracted from the medical records included only variables
required to calculate the final predictive score of the previously
developed scoring system. Surviving dogs were defined as those
remaining nondialysis dependent for at least 30 days after dis-
charge from the hospital. Dogs were excluded from the analysis if
euthanized within 2 weeks after initiation of hemodialysis because
of financial considerations but dogs euthanized ≥2 weeks after ini-
tiation of dialysis because of lack of improvement were considered
nonsurvivors.
Laboratory Findings
Blood and urine specimens were collected for CBC, serum bio-
chemistry profile, and urinalysis at admission, and analyses were
performed using established methods at the diagnostic laboratories
of the respective institutions. Urine production was measured
during the first 24 hours of hospitalization.
Organ System Involvement and Etiology
Etiology was classified when known as leptospirosis, ethylene
glycol intoxication, or other as previously described.3 Extra-renal
organ involvement was classified based on clinical signs, labora-
tory abnormalities, radiological or ultrasonographic findings, or
some combination of these as previously described.3
Calculation of Final Predictive Score
Formulas for the prototype predictive models A, B, and C have
been described previously.3 The clinical value for each required
variable was compared with previously established ranges for
assignment of the weighting factors for each dog’s calculation. All
weighting factors were added to produce a final predictive score
for each dog. Higher scores corresponded with a poorer prognosis
for survival.
Statistical Analysis
Descriptive statistics are presented as mean  standard devia-
tion or median and range based on evaluation of the data distribu-
tion under the normality assumption using the Shapiro-Wilk test.
One-way analysis of variance (ANOVA) was used to compare final
predicative scores among institutions. Proportions were compared
using the chi-square test. Logistic regression was used to assess the
relationship between the final predictive score and the probability
of 30-day survival. Receiver operating curve analysis was per-
formed to determine the area under the curve (AUC) and to calcu-
late sensitivity and specificity for survival at different cut-off
values. The optimal cut-off value was chosen to minimize outcome
misclassification. Statistical analyses were performed using statisti-
cal software.a For all tests, P < .05 was considered statistically sig-
nificant.
Results
Results of clinicopathologic variables assessed at
presentation and used to calculate final predictive scores
in the validation cohort are shown in Table 1. Median
urine production was 0.9 mL/kg/h (range 0–9.9 mL/kg/
h). Thirty-four dogs (30%) were anuric during the
initial 24 hours after presentation.
Table 1. Mean and standard deviation (SD) of vari-
able used to calculate the final predictive score of 115
dogs with acute kidney injury managed by hemodialysis.
Variable Mean SD
Red blood cells (9106 cells/lL) 5.0 1.4
Lymphocyte count (9103 cells/lL) 1.58 1.20
Creatinine (mg/dL) 10.0 4.5
Phosphorus (mg/dL) 13.4 5.7
Ionized calcium (mmol/L) 1.1 0.2
Anion gap (mmol/L) 25.9 9.3
Albumin (g/dL) 2.4 0.5
Alanine aminotransferase (U/L) 271 588
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Fifty-two dogs (45%) had respiratory involvement at
presentation, 11 dogs (9%) had neurologic involvement,
and 26 dogs (23%) fulfilled the criteria for a diagnosis
of disseminated intravascular coagulation (DIC). The
overall survival proportion was 51.3% (59/115 dogs).
Outcome scores ranged from 12 to 33 (mean,
19.7  4.1) in model A, from 12.2 to 36.3 (mean,
21.4  4.90) in model B, and from 5.3 to 37.3
(mean, 20.4  6.8) in model C. There were no statisti-
cally significant differences in the mean final predictive
score for any of the models among the different institu-
tions. Higher scores were significantly associated with
decreased probability of survival in all models
(P < .001).
The AUC of the ROC analyses for models A, B, and
C were 0.80, 0.81, and 0.85, respectively (Fig 1,
Table 2). The optimal cut-off point for the current
cohort for model A was 20, with predicted sensitivity
and specificity of 75% and 73%, respectively, and cor-
rectly classified survival outcome in 85 dogs (74%). The
optimal cut-off point for model B was 21.5, with pre-
dicted sensitivity and specificity of 77% and 80%,
respectively, and correctly classified survival outcome in
90 dogs (78%). The optimal cut-off point for Model C
was 21.8 with predicted sensitivity and specificity of
77% and 87%, respectively, and correctly classified sur-
vival outcome in 94 dogs (82%).
The previously established (prototype) cut-off value
for model A was 20. This cut-off value was identical to
the cut-off value for the validation cohort. Therefore,
the sensitivity and specificity predictions did not change
for this model. The prototype optimal cut-off value for
model B established in the previous study3 was 20.5.
This cut-off value generated slightly different sensitivity
and specificity predictions of 80% and 68%, respec-
tively, when applied to the validation cohort and cor-
rectly classified survival outcome in 74% of the dogs.
The prototype optimal cut-off value established for
model C was 19.9. This cut-off value resulted in sensi-
tivity and specificity predictions of 86% and 75%,
respectively, in the validation cohort and correctly clas-
sified survival outcome in 80% of dogs.
Additional sensitivity and specificity values generated
from different cut-off values used to increase or to
decrease sensitivity or specificity predictions are presented
in Table 3.
Discussion
A validated clinical scoring system with the potential
to predict outcomes effectively for patients requiring
renal replacement therapy can have considerable utility
to categorize the severity, prognosis, and categorization
of AKI. We have described a prototype scoring system
based on clinical variables statistically correlated with
disease outcomes.3 The accuracy reported for this scor-
ing system potentially was flawed by testing its perfor-
mance on the same patient population used for its
generation. This study was designed to validate inde-
pendently the performance and accuracy of the scoring
system in a novel and diverse population of dogs
undergoing hemodialysis for AKI.
The results of our study indicate that the overall per-
formance of the prototype scoring system was relatively
good at predicting survival outcome, when tested on an
independent validation cohort, despite being marginally
lower than previously reported. The overall mortality
rate for dogs with AKI in this study was comparable to
reports in human patients with AKI managed with
hemodialysis (32–52.5%)4 and in previous reports of
Fig 1. Receiver operating curve (ROC) for Models A, B, and C.
Models A, B, and C had associated AUC values equal to 0.80,
0.81, and 0.85, respectively.
Table 2. Area under the receiver operating curve for 3
models for prediction of survival of dogs with acute
kidney injury managed with hemodialysis.
Model AUC SE Interval of AUC P value
Model A 0.80 0.042 0.72–0.88 <.001
Model B 0.81 0.041 0.73–0.88 <.001
Model C 0.85 0.037 0.78–0.92 <.001
AUC, area under the curve; SE, standard error.
Table 3. Selected cut-off values and associated sensitivity and specificity predictions for scoring models for survival
in of dogs with acute kidney injury managed by hemodialysis.
Model A Model B Model C
Cut-off Sensitivity Specificity Cut-off Sensitivity Specificity Cut-off Sensitivity Specificity
16.0 32 99 18.8 51 91 13.7 34 95
20.0 75 73 20.5 71 80 19.9 71 80
25.0 98 21 26.0 98 30 24.6 97 43
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dogs with AKI managed medically (56–62%)1,2 or with
hemodialysis (56%).3 The comparable mortalities in
dogs managed with hemodialysis likely reflect the
greater severity of kidney injury in these dogs compared
with those treated medically. This is reflected by the
higher mean serum creatinine concentration for dogs
managed by hemodialysis.3
The prognosis of dogs with AKI managed by
hemodialysis is affected by several variables including
disease severity, number of organs involved, and
reversibility of kidney injury, which is influenced
directly by its severity and etiology.5 Etiology is a major
determinant of survival, presumably because of the
potential of the kidney to recover. The 2 prognostically
most important etiologies in the tested cohorts were
ethylene glycol intoxication, which is a relatively irre-
versible injury,6,7 and leptospirosis, which is readily
reversible.1,8,9 As expected, and model C (that incorpo-
rated etiology as a variable in the scoring system) was
the most accurate model in both the previous and cur-
rent evaluations. However, etiology often is unknown at
presentation when the decision to initiate hemodialysis
must be made and often remains unknown throughout
the course of the disease.
The relatively strong influence of etiology on outcome
in these studies suggests that the statistical relevance and
development of weighting factors for other etiologies rele-
vant to other clinical settings should be evaluated for
incorporation into the scoring algorithm. This could influ-
ence the importance and accuracy of AKI scoring in other
geographic regions where different etiologies predominate
or as the causes of AKI in dogs change over time with
emerging diseases, new therapeutic agents, and changes in
practice patterns. Only 6% of the dogs in the validation
cohort were diagnosed with ethylene glycol intoxication
compared with 27% in the previous study, and only 23%
were diagnosed with leptospirosis compared with 31% in
the previous study. Increased awareness by owners of
ethylene glycol intoxication and the introduction of multi-
valent leptospirosis vaccination, as well as regional differ-
ences in the validation cohort, likely decreased the
prevalence of these 2 etiologies and may have contributed
to the slight differences in performance and accuracy com-
pared with the previous evaluation. Assuming these trends
persist and the prevalence of leptospirosis and ethylene
glycol intoxication decrease further over time, the value of
these etiologies in prognostic modeling will decrease and
be replaced by more relevant etiologic variable or reliance
on scoring models without etiology variables. Models A
and B, which do not incorporate etiology as part of the
model, were associated with 73% and 76% correct classifi-
cation of survival outcome, respectively, demonstrating
objective assessment of survival probability still is achiev-
able exclusive of etiology. The clinical signs and clinico-
pathologic abnormalities included in the scoring system
may have served as proxies for the severity of the disease
as well as its etiology and potential for repair.
Using area under the ROC curves as an indicator of
model performance, the scoring system applied to the
validation cohort of dogs compared favorably with the
previous evaluation in which performance was tested on
the same dogs used for its formulation. It also per-
formed similarly to other scoring systems developed for
human patients and animals.10–13 The validation cohort
of dogs was derived from 3 geographically distinct
referral centers, of which 2 differed from the center used
in the previous study. Nevertheless, the score ranges for
all models and the optimal cut-off values were almost
identical to those reported previously. Their compara-
bility suggests that the severity of kidney injury is simi-
lar among dogs with AKI managed by hemodialysis in
both studies and suggests that the scoring system will
have utility in other independent populations of dogs
presenting similarly for evaluation and management.
A concern with this or any scoring system is the rela-
tively high misclassification arising when the final predic-
tive score is close to the cut-off value. The scoring
system is most accurate when the final predictive score is
either low or high and is more likely to misclassify out-
come when the score is close to the cut-off point. When
the score is close to the cut-off point, a small change in 1
of the clinical values has potential to move the final pre-
dictive score above or below the cut-off and alter the
predicted outcome. This also is an inherent limitation of
diagnostic tests using defined cut-off values to rule in or
rule out a disease. A way to overcome this limitation is
to define a “gray zone” of scores for which predictions
and recommendation are avoided, especially when out-
come predictions could discourage owners from pursu-
ing medical options. For the current scoring system, the
sensitivity and specificity of the models increased when
predictions were not made when the final predictive
score was within a defined “gray zone” (Table 3). Clini-
cians also may elect to use higher or lower cut-off values
to further emphasize sensitivity or specificity predictions.
By increasing the cut-off value, sensitivity will increase
(higher correct prediction that an animal will survive),
but this will be at the expense of decreased specificity
(higher false prediction that an animal will not survive).
The outcomes of dogs managed by hemodialysis are
affected by treatment duration, which in turn often is
limited by financial constraints. Repair and regeneration
of the injured kidney and compensatory hypertrophy
may persist over several months, and owners may not
be able financially to maintain their dogs on hemodialy-
sis for the prolonged time required to facilitate recovery
and achieve successful outcome. However, when finan-
cial constraints do not limit treatment duration, the
prognosis for survival may be better than forecasted by
the scoring system predicting outcome only for the first
30 days after presentation.
Scoring systems always should be applied judiciously
and with caution in individual patients, where misclassi-
fication can have detrimental consequences. Despite the
relatively high performance of this scoring system,
20–26% of the dogs were misclassified using models
in which etiology was unknown, and 20% were
misclassified even when etiology was known. Therefore,
scoring systems alone cannot supplant proper clinical
assessment or serve as a sole prognostic tool, but
rather should be incorporated as part of the overall
assessment.
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The proposed scoring system has been tailored for
dogs requiring hemodialysis and should not be used in
dogs with AKI that are managed medically until first
tested and validated in that patient population. Prog-
nostic factors in AKI dogs managed medically likely
differ from those of dogs managed by hemodialysis. For
example, hyperkalemia was not included in the current
scoring systems because, once hemodialysis is initiated,
dogs are unlikely to die from consequences of hyper-
kalemia. Conversely, hyperkalemia is more likely to
influence the prognosis of dogs managed medically.
A scoring system like that used in our study also can
be used to objectively compare or classify disease sever-
ity among different patient populations. The final pre-
dictive scores were comparable among all 3 institutions,
suggesting hemodialysis was initiated in patients with
equivalent degrees of AKI severity. This comparability
is likely due to the uniformity of guidelines used for
dialytic intervention employed by these 3 centers.
There are several limitations to this study. First, the
number of dogs included was relatively low compared
with the numbers used in the development and the evalu-
ation of scoring systems used in humans, which can
reach thousands.10–12 Second, dogs euthanized ≥2 weeks
after initiation of hemodialysis because of lack of
improvement were considered nonsurvivors. Some of
these dogs might have recovered if hemodialysis had
been continued for a longer period of time. Nonetheless,
in veterinary medicine, financial constraints are more
likely to influence advanced therapeutic decisions and
treatment duration than are favorable outcome predic-
tions, which may be linked to costly or extended thera-
pies. Scoring systems developed for veterinary patients
may be more relevant and practical if directed at predict-
ing outcomes within weeks as opposed to months.
In summary, scoring systems can be used as an addi-
tional tool to aid clinicians in the overall assessment of
dogs with AKI, managed by hemodialysis.
Footnote
a SPSS 22.0 for Windows, Chicago IL
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